Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2451061219
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lund, G. K.
Right arrow Articles by Saeed, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lund, G. K.
Right arrow Articles by Saeed, M.
(Radiology 2007;245:95-102.)
© RSNA, 2007


Cardiac Imaging

Prediction of Left Ventricular Remodeling and Analysis of Infarct Resorption in Patients with Reperfused Myocardial Infarcts by Using Contrast-enhanced MR Imaging1

Gunnar K. Lund, MD, Alexander Stork, MD, Kai Muellerleile, MD, Achim A. Barmeyer, MD, Martin P. Bansmann, MD, Meike Knefel, MD, Ulrike Schlichting, MD, Martin Müller, MD, Pablo E. Verde, Gerhard Adam, MD, Thomas Meinertz, MD, and Maythem Saeed, PhD

1 From the Departments of Cardiology (G.K.L., K.M., A.A.B., M.K., U.S., M.M., T.M.) and Diagnostic and Interventional Radiology (A.S., M.P.B., G.A.), University Hospital Eppendorf, Hamburg, Germany; Coordination Center for Clinical Trials, University of Düsseldorf, Düsseldorf, Germany (P.E.V.); and Department of Radiology, University of California–San Francisco, San Francisco, Calif (M.S.). Received July 14, 2006; revision requested September 18; revision received November 21; accepted January 8, 2007; final version accepted February 12. Address correspondence to G.K.L., Roentgeninstitut, Kaiserswerther Str 89, 40476 Düsseldorf, Germany (e-mail: lund{at}roentgeninstitut.de).


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 IMPLICATION FOR PATIENT CARE...
 References
 
Purpose: To prospectively evaluate the accuracy of clinical and cardiac magnetic resonance (MR) imaging parameters for predicting left ventricular (LV) remodeling by using follow-up imaging as reference standard, and to prospectively evaluate infarct resorption in patients with reperfused first myocardial infarcts.

Materials and Methods: The study was approved by the institutional ethics committee and all patients gave written informed consent. In 55 patients (48 men, seven women; mean age ± standard deviation, 56 years ± 13), contrast material–enhanced and cine MR imaging were performed 5 days ± 3 and 8 months ± 3 after myocardial infarction (MI). Microvascular obstruction (MO) and infarct size were estimated at first-pass enhancement (FPE) and delayed enhancement (DE) MR, respectively. Remodeling was defined as an increase in LV end-diastolic volume index of 20% or higher at follow-up. Differences in continuous and categorical data were analyzed by using Student t test and Fischer exact test as appropriate.

Results: Patients with remodeling (n = 13, 24%) had higher creatine kinase MB (P < .05), more anterior infarcts (P < .05), more often a reduced Thrombolysis in Myocardial Infarction flow (P < .05), larger infarct size at DE MR (P < .001), a greater extent of MO at FPE MR (P < .01), lower ejection fraction (P < .001) and higher LV end-systolic volume index (P < .01). Infarct size at DE MR was a powerful predictor for remodeling (odds ratio: 1.18, P < .001), demonstrating that the risk for remodeling increased 2.8-fold with each 10% increase in infarct size. Infarct size of 24% or more of LV area predicted remodeling with high sensitivity (92%), specificity (93%), and accuracy (93%). Infarct resorption was larger in patients with remodeling (P < .01).

Conclusion: Infarct size 24% or more of the LV area constitutes an important threshold to predict remodeling. Patients with remodeling develop disproportionate infarct resorption.

© RSNA, 2007


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 IMPLICATION FOR PATIENT CARE...
 References
 
Left ventricular (LV) remodeling after acute myocardial infarction (AMI) is an important element in the progression of cardiac insufficiency to overt heart failure and an early marker of increased morbitidy and mortality (1). Multiple factors contribute to remodeling, including anterior infarct location (2), patency of the infarct-related artery (3), LV ejection fraction (LVEF) (4), and estimation of infarct size by extent of contractile dysfunction (2,5), enzyme release (6), or nuclear imaging (7). More recent studies have underscored the impact of microvascular obstruction (MO) on the development of remodeling (4,8). By using myocardial contrast echocardiography, Ito et al (8) showed that the LV volume increased progressively in patients with MO, but not in patients without MO. Bolognese et al (4) suggested that presence of MO is an important predictor of remodeling and of unfavorable outcome in patients with successfully reperfused myocardial infarction (MI).

Contrast material–enhanced magnetic resonance (MR) imaging has the ability to generate several parameters predictive of remodeling including LV volume, LVEF, MO, and infarct size (911). Recent studies (11,12) showed that delayed enhancement (DE) MR correctly estimates infarct size in acute and chronic MI. Experimental data showed the accuracy of first-pass enhancement (FPE) MR in determining the extent of MO (13). The accuracy of MR imaging renders this technique as an attractive tool to identify patients at risk for remodeling. Furthermore, serially performed contrast-enhanced MR offers the possibility to study infarct resorption after AMI. Previous studies have uniformly shown that the infarct size decreases after MI (1417). However, factors that have an impact on infarct resorption and the relative changes in infarct size in patients with and those without remodeling are not well understood.

The purpose of the study was to prospectively evaluate the accuracy of clinical and cardiac MR imaging parameters for predicting LV remodeling by using follow-up imaging as reference standard, and to prospectively evaluate infarct resorption in patients with reperfused first MIs.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 IMPLICATION FOR PATIENT CARE...
 References
 
Study Protocol
The study was approved by the institutional ethics committee and all patients gave written informed consent. Sixty-eight consecutive patients with first MI were prospectively enrolled between April 2002 and June 2003. AMI was defined by prolonged chest pain, peak creatine kinase MB more than twice the normal upper limit of 5 U/L, and 1.0 mm or more ST segment elevation in two or more leads on the initial electrocardiogram. Patients were included if they had received reperfusion therapy by means of angioplasty or thrombolysis and had no contraindication to MR such as a pacemaker, intracranial metal, claustrophobia, or obesity over 150 kg total weight.

Patients were treated by using either direct angioplasty (n = 58) or thrombolytic therapy (n = 10). Coronary angiography was performed in all patients to identify the infarct-related artery. Perfusion of the infarct-related artery was determined at consensus reading by two observers (G.K.L. and M.P.B., 12 and 4 years experience reading coronary angiograms, respectively) by using the Thrombolysis in Myocardial Infarction trial criteria (18). Attending physicians performed medical treatment without knowledge of MR data because the initial MR study was completed after medical treatment was assigned.

Follow-up MR imaging was not performed in 13 patients: one died, two were lost to follow-up, three had an ischemic event in the follow-up period, and seven refused repetition of MR (Fig 1). The final study group comprised 55 patients (48 men, seven women; mean age ± standard deviation, 56 years ± 13). This number of patients guaranteed a study power of 90% or greater, owing to a clinical relevant probability to develop remodeling of 25% ± 10 (8,19) and a significance level of 5%.


Figure 1
View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1: Flow diagram of patient group.

 
MR Imaging
Initial and follow-up MR imaging was performed at 5 days ± 3 and 8 months ± 3 after MI, respectively, by using a 1.5-T system (Vision; Siemens, Erlangen, Germany) with a phased-array chest coil and electrocardiographic triggering. All images were acquired during breath hold in the double oblique LV short axis. Cine MR imaging was performed to measure LV function, volume, and mass by using a prospectively triggered steady-state free precession sequence (TrueFISP; Siemens). The imaging parameters were: repetition time msec/echo time msec, 3.6 /1.8; lines per segment, 13; section thickness, 8 mm; field of view, 350 x 306 mm (8:7 rectangular field of view); matrix, 256 x 224; pixel size, 1.37 x 1.37 mm. The sequence lasted approximately 12–15 seconds depending on the heart rate. Nine to 11 contiguous short-axis sections were acquired from LV apex to base.

FPE MR was used to detect regional MO, whereas DE MR was used to estimate infarct size. For FPE MR, a bolus of 0.1 mmol/kg gadopentetate dimeglumine (Magnevist; Schering, Berlin, Germany) per kilogram of body weight was injected into an antecubital vein followed by 20 mL of saline solution. Injection was performed at 3 mL/sec by using a power injector (Spectris MR Injector; Medrad, Indianola, Pa). Immediately after injection one image per R-R interval was acquired for the following 60 heartbeats by using an inversion-recovery prepared, T1-weighted turbo fast low-angle shot sequence. FPE MR was performed in the first 36 patients at a single midventricular level, whereas multisection imaging was performed in the subsequent 19 patients at the apical, midventricular, and basal LV levels. The imaging parameters were: 2.4/1.2; inversion time msec, 118; section thickness, 10 mm; field of view, 350 x 306 mm (8:7 rectangular field of view); matrix, 128 x 90; pixel size, 2.7 x 3.4 mm. Patients were asked to hold their breath for as long as possible and then allowed shallow breaths. The sequence lasted 50–60 seconds.

At 10 minutes after injection, multisection DE MR was performed in all patients at the apical, midventricular, and basal levels by using a segmented inversion-recovery prepared T1-weighted turbo fast low-angle shot sequence (20). The imaging parameters were: 7.6/3.4; inversion time msec, 220–300 to null the signal intensity of normal myocardium; delay after trigger, 400 msec; section thickness, 6 mm; field of view, 350 x 262 mm (8:6 rectangular field of view); matrix, 256 x 132; pixel size, 1.37 x 2.0 mm. Images were obtained every other heartbeat to give time for more complete inversion recovery. The sequence lasted approximately 15 seconds.

MR Data Analysis
Initial and follow-up images were transferred to a computer (Macintosh; Apple Computers, Cupertino, Calif) and data were analyzed by using a public domain program (NIH Image, version 1.62; U.S. National Institutes of Health, available at: http://rsb.info.nih.gov/nih-image/). All MR measurements were performed independently by two of three observers blinded to all other information (G.K.L., M.K., U.S., with 7, 3, and 3 years experience interpreting MR, respectively). Data are given as the mean of two observers. Presence of MO was identified on FPE MR images as an area of persistent subendocardial hypoenhancement with signal intensity less than two standard deviations than that of surrounding hyperenhanced myocardium (10).

Delayed enhancement was considered present if the signal intensity was more than two standard deviations than that of remote nonenhanced myocardium on DE MR (10). Signal intensity of remote myocardium was measured in three regions of interest with a size of 0.5 cm2, which were equally distributed in the middle of the nonenhanced myocardium. Mean signal intensity and standard deviation were obtained and the threshold level was calculated. Images were thresholded to these levels, and extent of MO and infarct size was measured and expressed as a percentage of LV area. On DE MR images, a zone of persistent subendocardial hypoenhancement surrounded by a hyperenhanced area was included in the measurement of infarct size (Fig 2) (21). Measurements were performed on each section and values were averaged between sections to obtain mean infarct or MO size per LV area.


Figure 2
View larger version (129K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2: Initial (upper row) and follow-up (lower row) MR images of patient with remodeling. Images show midventricular level of LV in short-axis view. An inversion-recovery T1-weighted turbo fast low-angle shot sequence was used for FPE MR (2.4/1.2/118) and DE MR (7.6/3.4/220–300); a steady-state free precession sequence was used for cine MR (3.6/1.8). At initial imaging, FPE image depicts extensive MO in the anteroseptal region (arrowheads) of LV. DE image shows large anteroseptal MI (black arrowheads) with persistent hypoenhancement in the subendocardium (white arrowheads). This zone of persistent subendocardial hypoenhancement was included in the measurement of infarct size. Diastolic cine image shows nondilated LV with normal wall thickness. At follow-up, no MO was observed on the FPE image. Infarct resorption is evident on DE image, especially in the lateral wall of LV (arrowheads), including resorption of subendocardial hypoenhancement present at initial study. Diastolic cine image shows dilated LV with thinned myocardium in infarcted region.

 
For evaluation of LV mass and volumes, the epicardial and endocardial borders of the myocardium were manually traced on end-diastolic and end-systolic images at each anatomic level encompassing the entire LV from apex to base. LV volumes were calculated by excluding the volume of papillary muscles. LV mass was calculated by multiplying the myocardial volume, including that of papillary muscles, by the specific weight of cardiac muscle (1.05 mg/mL) (22). LV mass and volumes were normalized to the individual body surface area and calculated by using a standard formula (23), resulting in LV end-diastolic volume index, LV end-systolic volume index, and LV mass index. Remodeling was defined as an increase in LV end-diastolic volume index of 20% or higher at follow-up (19).

Statistical Analysis, Reference Standard
Continuous measurements are summarized by using mean ± standard deviation. Differences in continuous data between or within groups were analyzed by using a two-sided Student t test for unpaired or paired data as appropriate. Categorical variables were compared by using the Fischer exact test. Logistic regression was performed by using multiple stepwise regression analysis to identify independent predictors of remodeling at 8 months after MI. In this analysis, all parameters were selected that had a P value of less than .1. LVEF was excluded because of known interdependency between LVEF and infarct size (1,15).

Receiver operating characteristic (ROC) analyses were performed to evaluate the diagnostic accuracy of the model to predict remodeling by using an increase in LV end-diastolic volume index of 20% or higher on follow-up imaging as the reference standard. Areas under the curve were determined and cutoff values were chosen to maximize the Youlden criterion for each parameter. Sensitivities, specificities, and diagnostic accuracies were determined with regard to each cutoff. A P value of less than .05 was required for significance. Statistical analysis was performed with SPSS for Windows (version 13.0; SPSS, Chicago, Ill).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 IMPLICATION FOR PATIENT CARE...
 References
 
Patient Characteristics
There were 42 patients without remodeling (76%, Table 1). Patients with remodeling (n = 13, 24%) had larger peak release of creatine kinase MB, more anterior infarcts, and a more often severely reduced Thrombolysis in Myocardial Infarction flow of the infarct-related artery before revascularization (Table 1). Patients with remodeling were more often assigned to treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. The percentage of patients treated with ß-blockers or diuretics was identical in both groups of patients.


View this table:
[in this window]
[in a new window]

 
Table 1. Clinical, Angiographic, and MR Characteristics in Patients with and Those without Remodeling at Initial Imaging

 
DE MR helped reveal that patients with remodeling had larger infarct sizes at initial imaging (28% of LV area ± 7) than did patients without remodeling (16% of LV area ± 9, P < .001). MO was more often present in patients with remodeling (nine of 13, 69%) compared with patients without remodeling (12 of 42, 29%, P < .01). The extent of MO was larger in patients with remodeling (11% of LV area ± 9) compared with patients without remodeling (3% of LV area ± 6, P < .01). Subgroup analysis revealed that presence of MO was not different in patients with single-section FPE MR (12 of 36, 33%) compared with patients with multisection FPE MR (nine of 19, 47%, P = .31). Also, the extent of MO was not different in patients with single-section FPE MR (5% of LV area ± 8) compared with patients with multisection FPE MR (5% of LV area ± 7, P = .72). Patients with remodeling had lower LVEF (39% ± 10 vs 55% ± 8, P < .001) and higher LV end-systolic volume index (46 mL/m2 ± 15 vs 34 mL/m2 ± 12, P < .01) at initial imaging than did patients without remodeling.

Clinical and MR Predictors of Remodeling
Stepwise multiple regression analysis was performed to evaluate independent predictors of remodeling. Clinical variables used for analysis were age, peak creatine kinase, peak creatine kinase MB, presence of q-wave infarct, infarct location, initial Thrombolysis in Myocardial Infarction flow, treatment with direct angioplasty, and stent placement in the infarct-related artery. MR variables were infarct size, presence and extent of MO, LVEF, LV end-diastolic volume index, LV end-systolic volume index, and LV mass index. For multiple regression analysis, factors showing a P value of less than .1 in univariate analysis were selected.

At initial imaging, a strong correlation was found between infarct size when measured by using DE MR and LVEF (r = 0.68, P < .001), displaying interdependency between the two parameters. LVEF was not included into subsequent multiple regression analyses because LVEF is a dependent variable of infarct size. Stepwise multiple regression analysis identified infarct size when measured by using DE MR as a powerful predictor for remodeling with an odds ratio of 1.18 (95% confidence interval: 1.07, 1.30; P < .001). This odds ratio demonstrated that the risk for remodeling increased 2.8-fold with each 10% increase in infarct size.

ROC Analysis
Infarct size, when measured by using DE MR, had the best test performance to predict remodeling with an area under the curve of 0.891 (Fig 3). Other estimates of myocardial injury such as extent of MO or peak release of creatine kinase MB were inferior to predict remodeling (Table 2). ROC analysis revealed that an infarct size of 24% or more of LV area was the best cutoff to predict remodeling. This cutoff resulted in a sensitivity of 92% and a specificity of 93% to predict remodeling. The correlation between infarct size at baseline and change in LV end-diastolic volume index 8 months after MI is shown in Figure 4.


Figure 3
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3: Graph shows ROC analysis to predict remodeling for different parameters of myocardial injury. Infarct size measured by using DE MR (solid line) was the best parameter to predict remodeling, with area under the curve = 0.891. Extent of MO measured by using FPE MR (dashed line) and peak creatine kinase MB (dotted line) were less predictive of remodeling. (Table 2).

 

View this table:
[in this window]
[in a new window]

 
Table 2. ROC Analyses

 

Figure 4
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4: Graph shows correlation between initial infarct size measured by using DE MR and change in LV end-diastolic volume index (LVEDVI) 8 months after MI (r = 0.56, P < .001). Vertical dotted line represents cutoff for infarct size 24% of LV area or higher to predict remodeling.

 
Infarct Resorption 8 Months after MI
Mean infarct size decreased by 5% LV area ± 7 from 19% LV area ± 10 at initial imaging to 14% LV area ± 8 at follow-up (P < .001). The relative reduction in infarct size was 26%, calculated as mean difference in infarct size between initial and follow-up imaging divided by mean infarct size at initial imaging. Patients with remodeling had larger infarct resorption from 28% ± 7 at initial imaging to 19% ± 9 at follow-up (–9% LV area ± 8) compared with patients without remodeling who had an infarct resorption of –4% LV area ± 7 from 17% ± 9 at initial imaging to 13% ± 7 at follow-up (P < .01).

Also, the relative reduction in infarct size was larger in patients with remodeling (–34% ± 26) compared with patients without remodeling (–12% ± 35, P < .05). A good correlation was found between infarct size at initial imaging and infarct resorption at follow-up (r = 0.65, P < .001, Fig 5), indicating that the initial infarct size determines later infarct resorption. At follow-up, the reduction in infarct size correlated with the increase in LV end-diastolic volume index (r = 0.41, P < .01), indicating that infarct resorption and remodeling are related processes.


Figure 5
View larger version (11K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5: Graph shows good correlation between initial infarct size measured by using DE MR and infarct resorption 8 months after MI (r = 0.65, P < .001). Patients with large infarcts at initial imaging had greatest infarct resorption at follow-up.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 IMPLICATION FOR PATIENT CARE...
 References
 
The results of our study demonstrate that infarct size, when measured by using DE MR, is a powerful predictor of remodeling in patients with reperfused MI. An infarct size of 24% or more of LV area predicted remodeling with high sensitivity and specificity at 8 months after AMI. The risk for remodeling increased 2.8-fold with each 10% increase in infarct size. Furthermore, patients with remodeling had a larger amount of infarct resorption compared with patients without remodeling. Our data indicate that remodeling and the amount of infarct resorption are related processes occurring after AMI. Contrast-enhanced MR enables important insights into the relationship between remodeling and infarct resorption after MI.

Prediction of Remodeling
Animal studies (1,24) showed that remodeling and subsequent changes in LV function are linearly related to infarct size. Clinical studies (24,7) suggested that several parameters are predictive of remodeling, including anterior infarct location, patency of the infarct-related artery, LVEF, and infarct size. In agreement with these findings, our study identified a number of parameters predictive of remodeling.

At initial imaging, an intense correlation was found between infarct size when measured by using DE MR and LVEF. This interdependency was of importance for multiple regression analysis. The two parameters had equal impact in the model, so one parameter had to be excluded. For identification of independent predictors, LVEF was removed from the analysis because this parameter is, by nature, the dependent variable of infarct size. Final multivariate analysis showed that infarct size when measured by using DE MR was a powerful independent predictor of remodeling.

The finding that MO was not an independent predictor of remodeling is somewhat in contradiction to previous MR studies (9,25). In an animal study, Gerber et al (25) showed that extent of MO was superior to infarct size to predict remodeling. However, the experimental findings are not directly transferable to our data for several reasons.

First, the animal study analyzed occurrence of remodeling at 10 days after MI. Previous data showed that early remodeling is mainly related to myocardial lengthening and thinning of the infarcted region, whereas the chronic period after MI is characterized by more complex geometric changes in the infarcted and the noninfarcted region (1). Therefore, the ultimate infarct size may represent a more important factor for later remodeling because it has an impact on the entire LV geometry (1).

Second, MI was induced in the animal study by using balloon occlusion of the left anterior descending artery for 90 minutes resulting in presence of MO in all animals. In our study, MO occurred in 38% of patients, which is typical for patients receiving modern reperfusion therapy (4,9). Presence of MO in all animals explains the dominant effect of this parameter in the experimental setting. Conversely, the lower frequency of MO in our study is most likely responsible for the reduced predictive value of this parameter in the clinical setting.

Threshold of Infarct Size for Remodeling
Previous studies suggested that a certain amount of myocardium has to be infarcted before remodeling occurs. On the basis of theoretical assumptions, Klein et al (26) suggested that LV enlargement occurs if 20%–25% of the LV area is noncontractile. A clinical study analyzed the effect of infarct size estimated by the extent of wall motion abnormality on remodeling (2). That study revealed that patients with a mean infarct size of 20% ± 3 LV area showed progressive LV dilatation at 3 years follow-up. Chareonthaitawee et al (7) studied the impact of infarct size obtained by means of sestamibi nuclear imaging on later LV function. That study found that only patients with an infarct size larger than 25% LV area demonstrated a relevant decrease in LVEF in the subsequent year.

Our data confirmed and extended the knowledge about the impact of infarct size on remodeling. ROC analysis revealed that an acute infarct size of 24% or more of LV area was the best cutoff to differentiate between remodeling and preservation of LV geometry. Furthermore, infarct size measured by using DE MR had a higher diagnostic accuracy for prediction of remodeling than enzymatic estimation of infarct size. An infarct size of 24% or higher of LV area constitutes an important threshold for later remodeling, indicating that the myocardium is severely injured and not able to maintain the LV geometry in future. Patients with an infarct size of 24% of LV area or more should be regularly monitored and intensively treated with antiremodeling drugs to prevent the progression of LV enlargement to overt heart failure.

Infarct Resorption
In our study, the contrast-enhanced region decreased by 26% from initial imaging to follow-up. Similar data were found by Hombach et al (17), who showed that the infarct size decreased by 28%, from 11.4% ± 7.2 to 7.8% ± 5.3 from 6 days to 8 months, respectively, after MI. Our findings are also consistent with those of two recently published studies performing the follow-up study earlier after the acute MI (14,15). Ingkanisorn et al (15) found a 31% decrease in infarct size more than 2 months after acute MI. Similarly, Choi et al (14) found a 27% decrease in infarct size over the same time period.

Our study additionally showed a link between infarct resorption and remodeling by performing acute and follow-up studies with DE MR and cine MR imaging. DE MR imaging demonstrated that patients with remodeling had substantially larger resorption of infarct size compared with patients without remodeling. Furthermore, the initial infarct size was directly related to later infarct resorption. Our data indicate that the acute infarct size has an impact on later infarct resorption. The linear relationship between the decrease in infarct size and the increase in LV end-diastolic volume index indicates that infarct resorption and remodeling are two related processes. Our data suggest that a larger necrosis in AMI results in a smaller scar, which is not able to maintain the shape of the LV in future. Therefore, limitation of infarct size should be the ultimate goal of infarct therapy to preserve acute LV function and to prevent later disproportionate infarct resorption and remodeling.

Limitations
Unlike infarct size, measurement of MO was not obtained from all patients at multisection imaging. Although subgroup analysis did not reveal any differences in presence and extent of MO in patients with single- and multisection FPE MR, this difference in the imaging strategy may have reduced the predictive value of MO for remodeling. Current imaging strategies enable multisection measurement of MO on four to five sections and multisection DE MR allows more accurate quantification of infarct size. These imaging strategies enable full coverage of the LV and should be included in future studies to overcome the current limitations.

Infarct size, when measured by using DE MR, can predict remodeling and can therefore be a tool for risk stratification of patients who recently experienced MI. An infarct size of 24% or more of LV area constitutes an important threshold indicating that the myocardium is not able to maintain the LV geometry in the future. Patients with such large infarcts should be intensively treated with antiremodeling therapy to prevent progressive remodeling to overt heart failure. Our study also showed a link between acute infarct size and later infarct resorption and remodeling. Patients with large infarcts not only have reduced LV function but also develop disproportionate infarct resorption and remodeling.


    ADVANCES IN KNOWLEDGE
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 IMPLICATION FOR PATIENT CARE...
 References
 


    IMPLICATION FOR PATIENT CARE
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 IMPLICATION FOR PATIENT CARE...
 References
 


    FOOTNOTES
 

Abbreviations: AMI = acute MI • DE = delayed enhancement • FPE = first-pass enhancement • LV = left ventricular • LVEF = LV ejection fraction • MI = myocardial infarction • MO = microvascular obstruction • ROC = receiver operating characteristic

Authors stated no financial relationship to disclose.

Author contributions: Guarantors of integrity of entire study, G.K.L., A.S., M.P.B.; study concepts/study design or data acquisition or data analysis/interpretation, all authors; manuscript drafting or manuscript revision for important intellectual content, all authors; approval of final version of submitted manuscript, all authors; literature research, G.K.L., M.S.; clinical studies, G.K.L., A.S., K.M., A.A.B., M.P.B., M.K., U.S., M.M., G.A., T.M.; statistical analysis, G.K.L., K.M., A.A.B., P.E.V.; and manuscript editing, G.K.L., A.S., P.E.V., G.A., M.S.


    References
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 IMPLICATION FOR PATIENT CARE...
 References
 

  1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161–1172.
  2. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation 1993;87:755–763. [Abstract/Free Full Text]
  3. Jeremy RW, Hackworthy RA, Bautovich G, Hutton BF, Harris PJ. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol 1987;9:989–995. [Abstract]
  4. Bolognese L, Carrabba N, Parodi G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004;109:1121–1126. [Abstract/Free Full Text]
  5. McKay RG, Pfeffer MA, Pasternak RC, et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 1986;74:693–702. [Abstract/Free Full Text]
  6. Peels KH, Visser CA, Dambrink JH, et al. Left ventricular wall motion score as an early predictor of left ventricular dilation and mortality after first anterior infarction treated with thrombolysis: the CATS Investigators Group. Am J Cardiol 1996;77:1149–1154. [CrossRef][Medline]
  7. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol 1995;25:567–573. [Abstract]
  8. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ‘no reflow’ phenomenon:a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223–228. [Abstract/Free Full Text]
  9. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765–772. [Abstract/Free Full Text]
  10. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083–1089. [Abstract/Free Full Text]
  11. Lund GK, Stork A, Saeed M, et al. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl-SPECT imaging. Radiology 2004;232:49–57. [Abstract/Free Full Text]
  12. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162–167. [Abstract/Free Full Text]
  13. Wu KC, Kim RJ, Bluemke DA, et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 1998;32:1756–1764. [Abstract/Free Full Text]
  14. Choi CJ, Haji-Momenian S, Dimaria JM, et al. Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction. J Cardiovasc Magn Reson 2004;6:917–925. [CrossRef][Medline]
  15. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253–2259. [Abstract/Free Full Text]
  16. Fieno DS, Hillenbrand HB, Rehwald WG, et al. Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J Am Coll Cardiol 2004;43:2124–2131. [Abstract/Free Full Text]
  17. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005;26:549–557. [Abstract/Free Full Text]
  18. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings—TIMI Study Group. N Engl J Med 1985;312:932–936.
  19. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002;106:2351–2357. [Abstract/Free Full Text]
  20. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215–223. [Abstract/Free Full Text]
  21. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36:1985–1991. [Abstract/Free Full Text]
  22. Semelka RC, Tomei E, Wagner S, et al. Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J 1990;119:1367–1373. [CrossRef][Medline]
  23. Dubois D, Dubois EF. A formula to estimate the approximate surface area if height and weight are known. Arch Intern Med 1916;17:863–871.
  24. Fletcher PJ, Pfeffer JM, Pfeffer MA, Braunwald E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction: effects on systolic function. Circ Res 1981;49:618–626. [Abstract/Free Full Text]
  25. Gerber BL, Rochitte CE, Melin JA, et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000;101:2734–2741. [Abstract/Free Full Text]
  26. Klein MD, Herman MV, Gorlin R. A hemodynamic study of left ventricular aneurysm. Circulation 1967;35:614–630. [Abstract/Free Full Text]



This article has been cited by other articles:


Home page
RadiologyHome page
R. Nijveldt, M. B. M. Hofman, A. Hirsch, A. M. Beek, V. A. W. M. Umans, P. R. Algra, J. J. Piek, and A. C. van Rossum
Assessment of Microvascular Obstruction and Prediction of Short-term Remodeling after Acute Myocardial Infarction: Cardiac MR Imaging Study
Radiology, February 1, 2009; 250(2): 363 - 370.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The year in cardiac imaging.
J. Am. Coll. Cardiol., January 6, 2009; 53(1): 54 - 70.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Yang, J. Linden, S. S. Berr, I. L. Kron, G. A. Beller, and B. A. French
Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2328 - H2335.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Saeed, A. Martin, A. Jacquier, M. Bucknor, D. Saloner, L. Do, P. Ursell, H. Su, Y. W. Kan, and C. B. Higgins
Permanent Coronary Artery Occlusion: Cardiovascular MR Imaging Is Platform for Percutaneous Transendocardial Delivery and Assessment of Gene Therapy in Canine Model
Radiology, November 1, 2008; 249(2): 560 - 571.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lund, G. K.
Right arrow Articles by Saeed, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lund, G. K.
Right arrow Articles by Saeed, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE